This site is intended for health professionals only

H1N1 and the role of secondary bacterial infections


As leading researchers continue to examine ways to prevent the spread of the H1N1 virus, new data has emerged about the link between H1N1 and secondary bacterial co-infections, including pneumococcal disease, which in past flu pandemics has been documented to be a significant cause of mortality and morbidity.

A report published in the 4 September CDC Morbidity & Mortality Weekly Report (MMWR) pointed to the risks for children younger than 5 years (even healthy children) who contract H1N1 and develop a secondary bacterial infection. To help mitigate this threat, experts have advised the use of the 7-valent pneumococcal conjugate vaccine in infants and toddlers to help prevent secondary infections caused by pneumococcal bacteria.


Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine